EC Healthcare Reports No Share Issuance in May 2026, Confirms Adequate Public Float

Bulletin Express06-03 10:03

EC Healthcare (02138) released its monthly return for the period ended 31 May 2026, indicating no changes to either authorised or issued share capital during the month.

Authorised and Issued Share Capital • Authorised share capital remained at 38.00 billion ordinary shares with a par value of HKD 0.00001, equivalent to HKD 0.38 million. • Issued share count was unchanged at 1.19 billion ordinary shares, and the company continued to hold zero treasury shares.

Public Float The company confirmed compliance with the Hong Kong Stock Exchange’s minimum 25% public-float requirement as at month-end.

Share Option Position • 2016 Share Option Scheme: 18.92 million options outstanding, unchanged month-on-month. • 2023 Share Option Scheme: 59.26 million options outstanding, unchanged month-on-month. • Aggregate outstanding options across both schemes total 78.18 million, representing approximately 6.60% of current issued shares. • No new shares were issued and no treasury shares were transferred during the month pursuant to option exercises, resulting in zero proceeds from option exercises.

Overall Activity The filing records no movements involving warrants, convertible securities, or other agreements to issue shares. The company affirmed that all regulatory and listing rule requirements related to its share capital and option schemes remain fully satisfied.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment